We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPHR:NYSESphere Entertainment Co. Analysis

Data as of 2026-09-11 - not real-time

$142.79

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Sphere Entertainment Co. is bullish at $142.79, with short-term averages leading the long-term ones. Over a rolling month the price has lost 3.7%. With RSI at 43.8 the momentum picture is neutral, alongside a bearish MACD signal. Watch $132.80 as support and $178.84 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 26.0% above where the shares trade now. Revenue is growing at 11.0% on a -5.7% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 54.7%, a beta of 1.32 and a maximum drawdown of 24.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 4/10 conviction.

Top Market Events

Sphere Entertainment Co SPHR reports a 30% revenue surge in its Sphere segment driven by 'The Wizard of Oz,' while...Microsoft and our third-party vendors use cookies to store and access information such as unique IDs and personal...Content production and distribution company Sphere Entertainment NYSE:SPHR reported Q2 CY2026 results exceeding the...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 124.87
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 124.87
  • Analyst targets imply +26.0% versus the current price

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Negative profit margin of -5.7%
  • Analyst targets imply +26.0% versus the current price
  • Negative return on equity of -3.1%

Key Metrics & Analysis

Financial Health

Revenue Growth11.00%
Profit Margin-5.66%
P/E Ratio-69.7
ROE-3.10%
ROA-1.25%
Debt/Equity40.99
P/B Ratio2.3
Op. Cash Flow$398.6M
Free Cash Flow$442.7M
Industry P/E15.5

Technical Analysis

TrendBullish
RSI43.8
Support$132.80
Resistance$178.84
MA 20$150.27
MA 50$149.84
MA 200$124.87
MACDBearish
VolumeDecreasing
Fear & Greed Index93.59

Valuation

Fair Value$235.31
Target Price$179.92
Upside/Downside26.01%
GradeFair
TypeBlend

Risk Assessment

Beta1.32
Volatility54.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.